Immumem Therapeutics Overview
- Year Founded
-
2024
- Status
-
Private
- Employees
-
2
- Latest Deal Type
-
Seed
- (Upcoming)
- Latest Deal Amount
-
$4M
- Investors
-
2
Immumem Therapeutics General Information
Description
Developer of cell-based therapies designed for the prevention of cancer relapse. The company's platform utilizes induced pluripotent stem cells to engineer memory T and NK cells, enabling patients with long-term immune surveillance against refractory solid tumors.
Contact Information
Website
www.immumemtx.comCorporate Office
- 447 Sutter Street
- Suite 506-1405
- San Francisco, CA 94108
- United States
Corporate Office
- 447 Sutter Street
- Suite 506-1405
- San Francisco, CA 94108
- United States
Immumem Therapeutics Timeline
Immumem Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Seed Round | $4M | Upcoming | Startup | |||
| 4. Equity Crowdfunding | Announced | Startup | ||||
| 3. Accelerator/Incubator | 29-Apr-2026 | Completed | Startup | |||
| 2. Grant | 16-Jul-2025 | $75K | Completed | Startup | ||
| 1. Grant | $50K | Completed | Startup |
Immumem Therapeutics Comparisons
Industry
Financing
Details
Immumem Therapeutics Competitors (16)
One of Immumem Therapeutics’s 16 competitors is Allogene Therapeutics, a Formerly VC-backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Allogene Therapeutics | Formerly VC-backed | South San Francisco, CA | ||||
| Century Therapeutics | Formerly VC-backed | Philadelphia, PA | ||||
| Kite Pharma | Formerly VC-backed | Santa Monica, CA | ||||
| Nkarta Therapeutics | Formerly VC-backed | South San Francisco, CA | ||||
| Adaptimmune Therapeutics | Formerly VC-backed | Abingdon, United Kingdom |
Immumem Therapeutics Signals
Immumem Therapeutics Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| LvlUp Ventures | Accelerator/Incubator | |||
| ScaleReady | Corporation |
Immumem Therapeutics FAQs
-
When was Immumem Therapeutics founded?
Immumem Therapeutics was founded in 2024.
-
Where is Immumem Therapeutics headquartered?
Immumem Therapeutics is headquartered in San Francisco, CA.
-
What is the size of Immumem Therapeutics?
Immumem Therapeutics has 2 total employees.
-
What industry is Immumem Therapeutics in?
Immumem Therapeutics’s primary industry is Biotechnology.
-
Is Immumem Therapeutics a private or public company?
Immumem Therapeutics is a Private company.
-
What is the current valuation of Immumem Therapeutics?
The current valuation of Immumem Therapeutics is .
-
What is Immumem Therapeutics’s current revenue?
The current revenue for Immumem Therapeutics is .
-
Who are Immumem Therapeutics’s investors?
LvlUp Ventures and ScaleReady have invested in Immumem Therapeutics.
-
Who are Immumem Therapeutics’s competitors?
Allogene Therapeutics, Century Therapeutics, Kite Pharma, Nkarta Therapeutics, and Adaptimmune Therapeutics are some of the 16 competitors of Immumem Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process